Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Purpose To conduct a retrospective evaluation of using dog as an animal model to study the fraction of oral dose absorbed (F) of 43 drugs in humans and to briefly discuss potential factors that might have contributed to the observed differences in absorption.Methods Mean human and dog absorption data obtained under fasted state of 43 drugs with markedly different physicochemical and pharmacological properties and with mean F values ranging from 0.015 to 1.0 were obtained from the literature. Correlation of F values between humans and dogs was studied. Based on the same references, additional F data for humans and rats were also obtained for 18 drugs.Results Among the 43 drugs studied, 22 drugs were virtually completely absorbed in both dogs and humans. However, the overall correlation was relatively poor (r2 = 0.5123) as compared to the earlier rat vs. human study on 64 drugs (r2 = 0.975). Several drugs showed much better absorption in dogs than in humans. Marked differences in the nonliner absorption profiles between the two species were found for some drugs. Also, some drugs had much longer Tmax values and prolonged absorption in humans than in dogs that might be theoretically predicted. Data on 18 drugs further support great similarity in F between humans and rats reported earlier from our laboratory.Conclusions Although dog has been commonly employed as an animal model for studying oral absorption in drug discovery and development, the present study suggests that one may need to exercise caution in the interpretation of data obtained. Exact reasons for the observed interspecies differences in oral absorption remain to be explored.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies may not specify translation or prediction in their title, e.g. [79, 80].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [80]
Citations
Cites
Gibaldi, M., & Perrier, D. (1982) · CRC Press eBooks · doi:10.1201/b14095 · Cited by 4,093
Kararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Comparison Between Permeability Coefficients in Rat and Human Jejunum
Fagerholm, U., Johansson, M., & Lennernäs, H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016065715308 · Cited by 438
Species similarities and differences in pharmacokinetics.
Lin, J. H. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06742-x · Cited by 395
Comparison of Canine and Human Gastrointestinal Physiology
Dressman, J. B. (1986) · Pharmaceutical Research · doi:10.1023/a:1016353705970 · Cited by 339
Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats
Chiou, W. L., & Barve, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981317451 · Cited by 257
Self-citationDrug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption
Balon, K., Riebesehl, B. U., & Müller, B. W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018882221008 · Cited by 199
He, Y.-L., Murby, S., Warhurst, G., Gifford, L., Walker, D., Ayrton, J., Eastmond, R., & Rowland, M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970120d · Cited by 176
Pharmacokinetics/pharmacodynamics of furosemide in man: A review
Benet, L. Z. (1979) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059438 · Cited by 153
Studies on the pharmacokinetics and pharmacodynamics of atenolol in man
Fitzgerald, J. D., Ruffin, R. E., Smedstad, K. G., Roberts, R., & McAinsh, J. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609750 · Cited by 126
Research works printed but not linked: 1
- Physicians' Desk Reference, 51th edition, pp. 1187-1190, Medical Economics company, Montvale, NJ, 1997.
Cited by
Clinical Pharmacokinetics of Atorvastatin
Lennern??s, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00005 · Cited by 623
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Expandable gastroretentive dosage forms
Klausner, E. A., Lavy, E., Friedman, M., & Hoffman, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00203-7 · Cited by 419
Species Differences in Pharmacokinetics and Pharmacodynamics
Toutain, P.-L., Ferran, A., & Bousquet-Mélou, A. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-10324-7_2 · Cited by 300
Animal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
O'Driscoll, C. M., & Griffin, B. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.012 · Cited by 296
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M. B., Brewster, M., Brouwers, J., Flanagan, T., Harwood, M., Heinen, C., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.010 · Cited by 279
Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development
Chiba, M., Ishii, Y., & Sugiyama, Y. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9103-6 · Cited by 228
Ward, K. W., & Smith, B. R. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.603 · Cited by 212
Animal versus human oral drug bioavailability: Do they correlate?
Musther, H., Olivares-Morales, A., Hatley, O. J. D., Liu, B., & Rostami Hodjegan, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.018 · Cited by 211
“One of the commonly known comprehensive reports carried out by Grass and Sinko (2002), utilising the dataset published by Sietsema (1989). There has been no attempt to expand the data within the 2002 report with any additional data published since then or refine some ambiguities in the original report. Anecdotal evide…”
InfluentialEhrhardt, C., & Kim, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3 · Cited by 183
Preclinical formulations for discovery and toxicology: physicochemical challenges
Neervannan, S. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.5.715 · Cited by 164
Takano, R., Furumoto, K., Shiraki, K., Takata, N., Hayashi, Y., Aso, Y., & Yamashita, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9637-9 · Cited by 158
Papich, M. G., & Martinez, M. N. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9743-7 · Cited by 181
Physiologically-based pharmacokinetic simulation modelling
Grass, G. M., & Sinko, P. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00013-3 · Cited by 160
Eriksson, U. G., Bredberg, U., Hoffmann, K., Thuresson, A., Gabrielsson, M., Ericsson, H., Ahnoff, M., Gislén, K., Fager, G., & Gustafsson, D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.294 · Cited by 153
Lucas, A. J., Sproston, J. L., Barton, P., & Riley, R. J. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1660642 · Cited by 163
Caldwell, G. W., Masucci, J. A., Yan, Z., & Hageman, W. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190588 · Cited by 148
“The in-vivo drug absorption (fa)measured in animals (rats and primates) has been shown to be agood predictor of in-vivo absorption in humans ( 48 - 51 ).”
BackgroundPrediction of human intestinal absorption of drug compounds
Radchenko, E. V., Дябина, А. С., Palyulin, V. A., & Zefirov, N. S. (2016) · Russian Chemical Bulletin · doi:10.1007/s11172-016-1340-0 · Cited by 137
Predictive ADMET studies, the challenges and the opportunities
Davis, A. M., & Riley, R. J. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.005 · Cited by 141
Klopman, G., Stefan, L. R., & Saiakhov, R. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00219-1 · Cited by 134
Introduction to computational oral absorption simulation
Sugano, K. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902835506 · Cited by 129
Applications of Physiologically Based Absorption Models in Drug Discovery and Development
Parrott, N., & Lave, T. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000155 · Cited by 122
Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and Human
Chiou, W. L., & Buehler, P. W. (2002) · Pharmaceutical Research · doi:10.1023/a:1016169202830 · Cited by 123
Self-citationKinetic Analyses for Species Differences in P-glycoprotein-Mediated Drug Transport
Katoh, M., Suzuyama, N., Takeuchi, T., Yoshitomi, S., Asahi, S., & Yokoi, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20686 · Cited by 111
Peters, S. A., Jones, C. R., Ungell, A.-L. B., & Hatley, O. J. D. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0351-6 · Cited by 117
The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies
Youhanna, S. C., & Lauschke, V. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.07.001 · Cited by 116
Hot-melt extrusion: Highlighting recent advances in pharmaceutical applications
Tambe, S. M., Jain, D. D., Agarwal, Y., & Amin, P. D. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102452 · Cited by 103
Nicolas, J., Bouzom, F., Chanteux, H., & Ungell, A.-L. B. (2017) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2052 · Cited by 106
Martinez, M. N. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00071-6 · Cited by 101
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Zerrouk, N., & Mura, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.005 · Cited by 100
Companion animal physiology and dosage form performance
Sutton, S. C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.013 · Cited by 100
Di, L., Feng, B., Goosen, T. C., Lai, Y., Steyn, S. J., Varma, M. V. S., & Obach, R. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054031 · Cited by 107
Prediction of human pharmacokinetics —gastrointestinal absorption
Fagerholm, U. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0001 · Cited by 107
Evaluation of rat intestinal absorption data and correlation with human intestinal absorption
Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B. S., & Cooper, I. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00015-1 · Cited by 96
Kaukonen, A. M., Laitinen, L., Salonen, J., Tuura, J., Heikkilä, T., Limnell, T., Hirvonen, J. J., & Lehto, V. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.021 · Cited by 94
IV-IVC considerations in the development of immediate-release oral dosage form
Li, S., He, H., Parthiban, L. J., Yin, H., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20378 · Cited by 105
Prediction of oral drug absorption in humans – from cultured cell lines and experimental animals
Cheng, K., Li, C., & Uss, A. S. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.581 · Cited by 85
Barker, R., Abrahamsson, B., & Kruusmägi, M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24177 · Cited by 84
Sanoh, S., Horiguchi, A., Sugihara, K., Kotake, Y., Tayama, Y., Ohshita, H., Tateno, C., Horie, T., Kitamura, S., & Ohta, S. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040923 · Cited by 83
Fagerholm, U. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.6.0007 · Cited by 76
Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule
Koziolek, M., Grimm, M. F., Bollmann, T., Schäfer, K. J., Blattner, S. M., Lotz, R. R. H., Boeck, G., & Weitschies, W. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.026 · Cited by 75
Liu, X., & Jia, L. (2007) · Current Drug Metabolism · doi:10.2174/138920007782798153 · Cited by 69
Jones, C. R., Hatley, O. J. D., Ungell, A.-L. B., Hilgendorf, C., Peters, S. A., & Rostami‐Hodjegan, A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9889-y · Cited by 72
Contrasting the Gastrointestinal Tracts of Mammals: Factors that Influence Absorption
DeSesso, J. M., & Williams, A. L. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00021-3 · Cited by 78
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review
Najafi, N., Mehri, S., Rahbardar, M. G., & Hosseinzadeh, H. (2022) · Phytotherapy Research · doi:10.1002/ptr.7406 · Cited by 69
Teksin, Z. Ş., Seo, P., & Polli, J. E. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9176-2 · Cited by 63
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., & Mura, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.004 · Cited by 62
Stoner, C. L., Cleton, A., Johnson, K., Oh, D.-M., Hallak, H., Brodfuehrer, J., Surendran, N., & Han, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.006 · Cited by 63
Takahashi, M., Washio, T., Suzuki, N., Igeta, K., & Yamashita, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21708 · Cited by 61
Sugano, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.02.002 · Cited by 58
Prediction of oral drug absorption in humans by theoretical passive absorption model
Obata, K., Sugano, K., Saitoh, R., Higashida, A., Nabuchi, Y., Machida, M., & Aso, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.005 · Cited by 56
Kagan, L., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.019 · Cited by 62
Dahlgren, D., Roos, C., Johansson, P., Tannergren, C., Lundqvist, A. J., Langguth, P., Sjöblom, M., Sjögren, E., & Lennernäs, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.029 · Cited by 55
Dog Colonoscopy Model for Predicting Human Colon Absorption
Sutton, S. C., Evans, L. A. F., Fortner, J. H., McCarthy, J. M., & Sweeney, K. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0252-3 · Cited by 50
Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products
Mitra, A., & Wu, Y. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9378-x · Cited by 50
Olivares‐Morales, A., Hatley, O. J. D., Turner, D. B., Galetin, A., Aarons, L. J., & Rostami‐Hodjegan, A. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1193-2 · Cited by 54
Tibbitts, J. (2003) · Toxicologic Pathology · doi:10.1080/01926230309776 · Cited by 49
Das, K., Madhusoodan, A. P., Mili, B., Kumar, A., Saxena, A. C., Kumar, K., Sarkar, M., Singh, P., Shrivastava, S., & Bag, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s122945 · Cited by 49
Excipient effects on gastrointestinal transit and drug absorption in beagle dogs
Schulze, J. D. R., Peters, E. E., Vickers, A. W., Staton, J. S., Coffin, M. D., Parsons, G. E., & Basit, A. W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.004 · Cited by 48
Drug compounding for veterinary patients
Papich, M. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070229 · Cited by 52
Computational Oral Absorption Simulation for Low‐Solubility Compounds
Sugano, K. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900101 · Cited by 48
Quantitative relationship between rat intestinal absorption and Abraham descriptors
Zhao, Y. H., Abraham, M. H., Hersey, A., & Luscombe, C. N. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.07.005 · Cited by 45
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human
Ward, K. W., Nagilla, R., & Jolivette, L. J. (2005) · Xenobiotica · doi:10.1080/00498250400028197 · Cited by 43
Neirinckx, E., Vervaet, C., Michiels, J., SMET, S. D., Broeck, W. V. D., Remon, J. P., Backer, J. F. A. D., & Croubels, S. (2010) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2010.01218.x · Cited by 42
Rationale and strategies for formulation development of oral fixed dose combination drug products
Moon, C., & Oh, E. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0286-4 · Cited by 39
Sanoh, S., & Ohta, S. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1864 · Cited by 39
Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics
Macedo, L. D. O., Masiero, J. F., & Bou‐Chacra, N. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091141 · Cited by 42
Characterization of Gastrointestinal Drug Absorption in Cynomolgus Monkeys
Takahashi, M., Washio, T., Suzuki, N., Igeta, K., Fujii, Y., Hayashi, M., Shirasaka, Y., & Yamashita, S. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700095p · Cited by 39
Dahlgren, D., Roos, C., Johansson, P., Lundqvist, A. J., Tannergren, C., Abrahamsson, B., Sjögren, E., & Lennernäs, H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00515 · Cited by 39
Zane, P. A., Gieschen, H., Kersten, E., Mathias, N. R., Ollier, C., Johansson, P., den Bergh, A. V., Hemelryck, S. V., Reichel, A., Rotgeri, A., et al. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.010 · Cited by 38
Yang, Z., Zadjura, L. M., D’Arienzo, C. J., Marino, A., Santone, K. S., Klunk, L. J., Greene, D. S., Lin, P., Colonno, R. J., Wang, T., et al. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.471 · Cited by 37
In Silico Models to Predict Oral Absorption
Waterbeemd, H. V. D. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00145-0 · Cited by 41
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs
Matsumura, N., Ono, A., Akiyama, Y., Fujita, T., & Sugano, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090844 · Cited by 35
Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro , and Preclinical Models
Price, E., Kalvass, J. C., DeGoey, D. A., Hosmane, B. S., Doktor, S. Z., & Desino, K. E. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00669 · Cited by 33
Chiou, W. L., Chung, S. M., & Wu, T. C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007573531947 · Cited by 33
Self-citationYates, D. T., Camacho, L. E., Kelly, A. C., Steyn, L. V., Davis, M. A., Antolic, A. T., Anderson, M. J., Goyal, R., Allen, R. E., Papas, K. K., et al. (2019) · The Journal of Physiology · doi:10.1113/jp278726 · Cited by 35
Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582
Fagerholm, U., & Björnsson, M. A. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0004 · Cited by 33
Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys
Furukawa, T. Y., Naritomi, Y., Tetsuka, K., Nakamori, F., Moriguchi, H., Yamano, K., Terashita, S., Tabata, K., & Teramura, T. (2013) · Xenobiotica · doi:10.3109/00498254.2013.828362 · Cited by 33
Chemical–biological interactions in human
Verma, R. P., Kurup, A., Mekapati, S. B., & Hansch, C. H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.064 · Cited by 26
Griffin, B. T., & O’Driscoll, C. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3_2 · Cited by 27
Zane, P. A., Guo, Z., MacGerorge, D., Vicat, P., & Ollier, C. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.018 · Cited by 24
Gastrointestinal transit of liquids in unfed cynomolgus monkeys
Kondo, H., Takahashi, Y., Watanabe, T., Yokohama, S., & Watanabe, J. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.348 · Cited by 24
Stockis, A., Sargentini‐Maier, M. L., Otoul, C., Connor, A. L., Wilding, I. R., & Wray, H. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.09.001 · Cited by 24
Ikegami, K., Tagawa, K., & Osawa, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20537 · Cited by 23
Giuliano, C., Fiore, F., Marco, A. D., Velazquez, J. P., Bishop, A., Bonelli, F., Paz, O. G., Marcucci, I., Harper, S., Narjes, F., et al. (2005) · Xenobiotica · doi:10.1080/00498250500356548 · Cited by 22
Harrison, A. C., Betts, A. M., Fenner, K. S., Beaumont, K. C., Edgington, A., Roffey, S. J., Davis, J. D., Comby, P., & Morgan, P. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.197 · Cited by 20
Khan, M. Z., Yousuf, R. I., Shoaib, M. H., Ahmed, F. R., Saleem, M. T., Siddiqui, F., & Rizvi, S. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104323 · Cited by 19
Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs
Akiyama, Y., Kimoto, T., Mukumoto, H., Miyake, S., Ito, S., Taniguchi, T., Nomura, Y., Matsumura, N., Fujita, T., & Sugano, K. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.03.015 · Cited by 20
The Biopharmaceutics Classification System
Lennernäs, H., & Abrahamsson, B. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00137-1 · Cited by 20
Metabolism and pharmacokinetic optimization strategies in drug discovery
Ballard, P. G., Brassil, P. J., Bui, K., Dolgos, H., Petersson, C., Tunek, A., & Webborn, P. J. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-4299-7.00010-x · Cited by 22
Zhang, M., Zhou, D., Wang, Y., Maier, D. L., Widzowski, D., Sobotka‐Briner, C. D., Brockel, B. J., Potts, W. M., Shenvi, A. B., Bernstein, P. R., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.174433 · Cited by 19
Thomas, S. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700507 · Cited by 21
McInnes, F. J., Clear, N., Humphrey, M., & Stevens, H. N. E. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9462-6 · Cited by 18
Pros and cons of methods used for the prediction of oral drug absorption
Fotaki, N. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2.2.195 · Cited by 21
Tanno, F. K., Sakuma, S., Masaoka, Y., Kataoka, M., Kozaki, T., Kamaguchi, R., Ikeda, Y., Kokubo, H., & Yamashita, S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21382 · Cited by 19
Integrating computer-based de novo drug design and multidimensional filtering for desirable drugs
Shimada, J., Ekins, S., Elkin, C., Shakhnovich, E. I., & Wery, J. (2002) · TARGETS · doi:10.1016/s1477-3627(02)02274-2 · Cited by 17
Key Considerations in Designing Oral Drug Delivery Systems for Dogs
Song, Y., Peressin, K. F., Wong, P. Y., Page, S. W., & Garg, S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.03.007 · Cited by 16
Veterinary Application of In Vitro Dissolution Data and the Biopharmaceutics Classification System
Martinez, M. N., Papich, M. G., & Riviere, J. E. (2013) · Cited by 15
Metadata
- Authors
- Chiou, W. L., Jeong, H. Y., Chung, S. M., & Wu, T. C.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Chiou, Win L.
- ORCID
- Chiou, Win L.
- Venue
- Pharmaceutical Research
- Published
- 2000-02
- Volume
- 17
- Issue
- 2
- Pages
- 135-140
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1517652134
- Cited by
- 182
- References
- 27
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 1 · 2023: 3 · 2022: 8 · 2021: 4 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 8 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 11
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- oral drug absorption, nonlinear absorption, Tmax, oral bioavailability
- MeSH terms
- Acids, Acyclovir, Administration, Oral, Alkalies, Animals, Antihypertensive Agents, Antiviral Agents, Chlorothiazide, Dogs, Enzyme Inhibitors, Fasting, Humans, Intestinal Absorption, Pharmacokinetics, Regression Analysis, Retrospective Studies, Species Specificity, Acarbose, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.